BEE VECTORING TECHNOLOGIES INTERNATIONAL INC. (via TheNewswire)
 | |||||||||
 |  |  |  | ||||||
Syensqo, a newly formed €8 billion company is a science and innovation pioneer in specialty chemicals and materials. Syensqo was formed following the spinoff of Solvay’s (SOLB.BR) specialty materials and chemicals businesses into an independent publicly-traded company at the end of 2023.
“Collaborating with Syensqo is a huge extension of our R&D efforts,” said
“Fast-tracking BVT into soybean crops through the well-established seed coating market will expand the Company’s addressable market beyond bee vectoring, bringing CR-7 to more growers by tapping into approaches they are already familiar with. BVT’s go-to market strategy is to commercialize this new CR-7 seed treatment product for sale through large agriculture suppliers, partners and distributors,” continued
Seed treatment helps germinating plants by protecting them against soil pests and diseases while boosting early-stage emergence and vigor, allowing the crop to establish quickly and reach its yield potential. The advantage of this approach is early protection: seed treatments protect the vulnerable growth stage of emerging seedlings from diseases caused by soil borne fungi. It also aligns with BVT’s core function of precision; seed treatments use a very small amount of product, often mere ounces per hundred pounds of seed. It is also popular with growers since it is a relatively easy application and they often receive seeds from distributors with the product already applied.
BVT’s CR-7 is also a proven entity in improving soybean yield and quality.Recent US trialsshowed wherever CR-7 was applied, the results outperformed the base seed treatment 81% of the time. On average, a three-bushel yield per acre increase was reported with CR-7 added, which is about 4% higher than the base seed treatment. This is in addition to previous successful trials in2021, which also showed CR-7 to be an effective treatment against Sudden Death Syndrome (SDS), a huge challenge for soybean growers. In these trials, soybean seeds were treated with CR-7 along with other seed treatment products before planting.
“Syensqo has proven expertise and proprietary IP on the formulation of seed treatments,” said Dr.
“In essence, this partnership is taking a proven, standard approach, and combining it with an innovative product – to get CR-7 as a seed treatment,” said
Soybeans represent a significant market opportunity for BVT. There are 320 million acres planted worldwide, with 86 million in the US, 98 million in
(1)Source: USDA, World Agricultural Production, 2022
(2)Source:
About
BVT, an agriculture technology company, is a market disruptor with a significant global market opportunity in the
Additional information can be viewed at the Company’s websitewww.beevt.com. To receive regular news updates from the Company, subscribe atwww.beevt.com/newsletter.
BVT Company Contact:
info@beevt.com
BVT Investor Contacts:
Tel: 416-646-6779
bpedram@virtusadvisory.com
The CSE has neither approved nor disapproved the contents of this press release. The CSE does not accept responsibility for the adequacy or accuracy of this release. Certain statements contained in this press release constitute "forward-looking information" as such term is defined in applicable Canadian securities legislation. The words "may", "would", "could", "should", "potential", "will", "seek", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions as they relate to the Company, “annual revenue potential”, are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company’s current views and intentions with respect to future events, and current information available to the Company, and are subject to certain risks, uncertainties and assumptions, including: planted acres, selling price of competitive chemical pesticides and the US to Canadian dollar exchange rate. Material factors or assumptions were applied in providing forward-looking information. Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. These factors include changes in law, competition, litigation, the ability to implement business strategies and pursue business opportunities, state of the capital markets, the availability of funds and resources to pursue operations, new technologies, the ability to protect intellectual property rights, the ability to obtain patent protection for products, third-party intellectual property infringement claims,regulatory changes affecting products, failing research and development activities, the ability to reach and sustain profitability, dependence on business and technical experts, the ability to effectively manage business operations and growth, issuance of debt, dilution of existing securities, volatility of publicly traded securities, potential conflicts of interest, unlikelihood of dividend payments, the potential costs stemming from defending third-party intellectual property infringement claims, the ability to secure relationships with manufacturers and purchasers, as well as general economic, market and business conditions, as well as those risk factors discussed or referred to in the Company’s Filing Statement dated
Copyright (c) 2024 TheNewswire - All rights reserved.
Copyright (c) 2024 TheNewswire - All rights reserved., source
